| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Vascular Stiffness | 19 | 2020 | 264 | 9.68 | Why? |
| Pulse Wave Analysis | 18 | 2019 | 221 | 6.22 | Why? |
| Coronary Artery Disease | 28 | 2020 | 2570 | 5.82 | Why? |
| Hypertension | 42 | 2020 | 8895 | 5.44 | Why? |
| Blood Pressure | 30 | 2019 | 2198 | 5.27 | Why? |
| Aortic Valve Stenosis | 14 | 2019 | 741 | 4.45 | Why? |
| Heart Failure | 34 | 2020 | 6638 | 4.33 | Why? |
| Atrial Fibrillation | 17 | 2019 | 2320 | 4.06 | Why? |
| Cardiovascular Diseases | 51 | 2020 | 11497 | 3.91 | Why? |
| Carotid Artery Diseases | 9 | 2019 | 251 | 3.87 | Why? |
| Heart Rate | 16 | 2019 | 1527 | 3.84 | Why? |
| Peripheral Arterial Disease | 9 | 2019 | 471 | 3.78 | Why? |
| Plaque, Atherosclerotic | 10 | 2018 | 423 | 3.77 | Why? |
| Stroke Volume | 16 | 2019 | 2153 | 3.70 | Why? |
| Ventricular Function, Left | 15 | 2019 | 1555 | 3.66 | Why? |
| Cardiac Resynchronization Therapy | 8 | 2019 | 191 | 3.44 | Why? |
| Transcatheter Aortic Valve Replacement | 11 | 2019 | 839 | 3.39 | Why? |
| Aorta | 11 | 2019 | 355 | 3.35 | Why? |
| Aortic Valve | 9 | 2019 | 664 | 3.24 | Why? |
| Sympathectomy | 8 | 2018 | 67 | 3.17 | Why? |
| Carotid Arteries | 8 | 2019 | 182 | 2.99 | Why? |
| Atherosclerosis | 10 | 2021 | 768 | 2.90 | Why? |
| Greece | 41 | 2020 | 2091 | 2.89 | Why? |
| Echocardiography, Stress | 4 | 2019 | 65 | 2.85 | Why? |
| Pericarditis | 7 | 2019 | 417 | 2.64 | Why? |
| Mitral Valve Insufficiency | 5 | 2019 | 302 | 2.59 | Why? |
| Coronary Angiography | 21 | 2019 | 2275 | 2.43 | Why? |
| Antihypertensive Agents | 16 | 2019 | 1962 | 2.39 | Why? |
| Platelet Aggregation Inhibitors | 9 | 2019 | 1671 | 2.38 | Why? |
| Heart Ventricles | 8 | 2019 | 1139 | 2.31 | Why? |
| Hypertrophy, Left Ventricular | 5 | 2019 | 219 | 2.28 | Why? |
| Dobutamine | 4 | 2019 | 36 | 2.27 | Why? |
| Hemodynamics | 12 | 2019 | 1562 | 2.16 | Why? |
| Acute Coronary Syndrome | 12 | 2020 | 2107 | 2.14 | Why? |
| Arrhythmias, Cardiac | 10 | 2020 | 2510 | 2.10 | Why? |
| Radial Artery | 4 | 2018 | 132 | 2.05 | Why? |
| Cardiac Catheterization | 8 | 2019 | 882 | 2.02 | Why? |
| Arterial Pressure | 4 | 2019 | 208 | 2.01 | Why? |
| Renal Artery | 3 | 2018 | 66 | 2.01 | Why? |
| Coronary Vessels | 10 | 2019 | 914 | 1.98 | Why? |
| Graft Occlusion, Vascular | 3 | 2019 | 105 | 1.98 | Why? |
| Electrocardiography | 19 | 2020 | 3957 | 1.95 | Why? |
| Cardiomyopathy, Hypertrophic | 3 | 2019 | 193 | 1.88 | Why? |
| Angioplasty, Balloon, Coronary | 4 | 2019 | 365 | 1.83 | Why? |
| Heart Atria | 6 | 2019 | 267 | 1.82 | Why? |
| Echocardiography, Doppler, Color | 4 | 2019 | 114 | 1.76 | Why? |
| Biomarkers | 40 | 2020 | 23361 | 1.74 | Why? |
| Atrial Remodeling | 3 | 2019 | 31 | 1.70 | Why? |
| Heart Valve Prosthesis Implantation | 6 | 2018 | 552 | 1.63 | Why? |
| Endothelium, Vascular | 12 | 2019 | 1751 | 1.62 | Why? |
| Sympathetic Nervous System | 4 | 2019 | 111 | 1.61 | Why? |
| Coronary Artery Bypass | 6 | 2019 | 629 | 1.60 | Why? |
| Osteoprotegerin | 2 | 2020 | 32 | 1.56 | Why? |
| Myocardial Contraction | 3 | 2019 | 123 | 1.54 | Why? |
| Kidney | 9 | 2018 | 3648 | 1.53 | Why? |
| Percutaneous Coronary Intervention | 10 | 2019 | 3646 | 1.52 | Why? |
| Baroreflex | 2 | 2019 | 54 | 1.52 | Why? |
| Echocardiography, Three-Dimensional | 3 | 2019 | 135 | 1.52 | Why? |
| Aortic Coarctation | 3 | 2018 | 21 | 1.50 | Why? |
| Stents | 5 | 2019 | 916 | 1.50 | Why? |
| Cardiac Catheters | 2 | 2019 | 44 | 1.47 | Why? |
| Myocardial Ischemia | 5 | 2020 | 781 | 1.42 | Why? |
| Aortic Diseases | 3 | 2019 | 362 | 1.42 | Why? |
| Humans | 289 | 2021 | 930598 | 1.42 | Why? |
| Arteries | 3 | 2019 | 283 | 1.41 | Why? |
| Tachycardia, Ventricular | 5 | 2019 | 251 | 1.40 | Why? |
| Saphenous Vein | 2 | 2019 | 67 | 1.38 | Why? |
| Inflammation | 20 | 2020 | 13255 | 1.38 | Why? |
| Caffeine | 2 | 2018 | 67 | 1.37 | Why? |
| Cell-Derived Microparticles | 2 | 2019 | 134 | 1.37 | Why? |
| Echocardiography | 22 | 2020 | 3661 | 1.37 | Why? |
| Diet, Western | 2 | 2017 | 42 | 1.35 | Why? |
| Vasodilation | 3 | 2020 | 258 | 1.31 | Why? |
| Heart Valve Prosthesis | 5 | 2019 | 533 | 1.29 | Why? |
| Coronary Occlusion | 2 | 2018 | 138 | 1.27 | Why? |
| Autonomic Nervous System | 2 | 2019 | 148 | 1.25 | Why? |
| Pacemaker, Artificial | 4 | 2018 | 431 | 1.24 | Why? |
| Prognosis | 41 | 2021 | 32490 | 1.24 | Why? |
| Electronic Nicotine Delivery Systems | 3 | 2019 | 561 | 1.19 | Why? |
| Myocardial Infarction | 8 | 2019 | 3361 | 1.19 | Why? |
| Foramen Ovale, Patent | 2 | 2018 | 153 | 1.18 | Why? |
| Body Temperature | 4 | 2018 | 875 | 1.18 | Why? |
| Death, Sudden, Cardiac | 7 | 2019 | 522 | 1.16 | Why? |
| Non-ST Elevated Myocardial Infarction | 3 | 2019 | 490 | 1.16 | Why? |
| Blood Pressure Determination | 8 | 2019 | 450 | 1.13 | Why? |
| Pregnancy Complications, Cardiovascular | 2 | 2018 | 231 | 1.13 | Why? |
| Coronary Stenosis | 2 | 2019 | 273 | 1.12 | Why? |
| Cardiology Service, Hospital | 3 | 2020 | 602 | 1.12 | Why? |
| Diabetes Mellitus, Type 2 | 10 | 2018 | 6166 | 1.11 | Why? |
| Insulin Resistance | 5 | 2019 | 669 | 1.10 | Why? |
| Genetic Testing | 2 | 2018 | 395 | 1.10 | Why? |
| MicroRNAs | 8 | 2019 | 1787 | 1.10 | Why? |
| Fatty Acids, Omega-3 | 2 | 2018 | 306 | 1.09 | Why? |
| Vascular Calcification | 3 | 2019 | 396 | 1.09 | Why? |
| Exercise Tolerance | 3 | 2018 | 634 | 1.09 | Why? |
| Echocardiography, Transesophageal | 5 | 2018 | 447 | 1.08 | Why? |
| Catheterization, Peripheral | 2 | 2018 | 249 | 1.06 | Why? |
| Risk Factors | 63 | 2020 | 71621 | 1.06 | Why? |
| Electrophysiologic Techniques, Cardiac | 2 | 2018 | 396 | 1.03 | Why? |
| Cigarette Smoking | 2 | 2019 | 337 | 1.03 | Why? |
| Heart Diseases | 8 | 2020 | 3503 | 1.02 | Why? |
| Coffee | 3 | 2018 | 79 | 0.98 | Why? |
| Radiometry | 3 | 2018 | 136 | 0.98 | Why? |
| Intestines | 2 | 2019 | 817 | 0.97 | Why? |
| Cardiovascular System | 5 | 2019 | 750 | 0.96 | Why? |
| Diet, Mediterranean | 6 | 2019 | 351 | 0.95 | Why? |
| Myocardium | 7 | 2019 | 2323 | 0.94 | Why? |
| Osteopontin | 2 | 2020 | 96 | 0.94 | Why? |
| Metabolic Syndrome | 4 | 2019 | 810 | 0.93 | Why? |
| Colchicine | 5 | 2021 | 730 | 0.93 | Why? |
| Microwaves | 3 | 2018 | 88 | 0.89 | Why? |
| Rest | 2 | 2019 | 188 | 0.89 | Why? |
| Regional Blood Flow | 4 | 2017 | 172 | 0.89 | Why? |
| Male | 120 | 2020 | 367725 | 0.88 | Why? |
| Olive Oil | 2 | 2018 | 46 | 0.88 | Why? |
| Defibrillators, Implantable | 5 | 2019 | 624 | 0.88 | Why? |
| Denervation | 2 | 2017 | 26 | 0.86 | Why? |
| Ventricular Dysfunction, Left | 6 | 2019 | 993 | 0.86 | Why? |
| Treatment Outcome | 42 | 2021 | 51732 | 0.85 | Why? |
| Catheter Ablation | 4 | 2019 | 438 | 0.84 | Why? |
| Myocardial Reperfusion Injury | 2 | 2019 | 129 | 0.84 | Why? |
| Hypolipidemic Agents | 3 | 2018 | 208 | 0.84 | Why? |
| Exfoliation Syndrome | 1 | 2019 | 2 | 0.83 | Why? |
| Pericardial Effusion | 3 | 2019 | 312 | 0.82 | Why? |
| Adrenergic beta-Antagonists | 2 | 2018 | 465 | 0.82 | Why? |
| Cardiotoxicity | 3 | 2018 | 365 | 0.81 | Why? |
| Polymorphism, Genetic | 5 | 2018 | 1074 | 0.81 | Why? |
| Femoral Artery | 3 | 2019 | 213 | 0.81 | Why? |
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 5 | 2020 | 1510 | 0.81 | Why? |
| Cryosurgery | 2 | 2017 | 57 | 0.80 | Why? |
| Arteriosclerosis | 1 | 2019 | 50 | 0.80 | Why? |
| Adrenergic beta-1 Receptor Agonists | 1 | 2019 | 6 | 0.79 | Why? |
| Systole | 2 | 2019 | 252 | 0.79 | Why? |
| Hyperparathyroidism, Secondary | 1 | 2019 | 47 | 0.79 | Why? |
| Ventricular Outflow Obstruction | 1 | 2019 | 23 | 0.79 | Why? |
| Diagnostic Techniques, Cardiovascular | 2 | 2017 | 144 | 0.78 | Why? |
| Vasa Vasorum | 1 | 2018 | 2 | 0.78 | Why? |
| Aged | 80 | 2020 | 215776 | 0.77 | Why? |
| Pancreas, Artificial | 1 | 2018 | 10 | 0.77 | Why? |
| Animals | 37 | 2019 | 78931 | 0.77 | Why? |
| Neovascularization, Physiologic | 2 | 2018 | 160 | 0.77 | Why? |
| Atherectomy, Coronary | 1 | 2019 | 35 | 0.77 | Why? |
| Bone Density Conservation Agents | 2 | 2019 | 209 | 0.77 | Why? |
| Electrocardiography, Ambulatory | 2 | 2018 | 204 | 0.77 | Why? |
| Foramen Ovale | 1 | 2018 | 4 | 0.76 | Why? |
| Natriuretic Peptides | 5 | 2019 | 66 | 0.76 | Why? |
| Aspirin | 2 | 2018 | 1043 | 0.76 | Why? |
| Calcinosis | 3 | 2019 | 240 | 0.76 | Why? |
| Balloon Valvuloplasty | 1 | 2019 | 49 | 0.76 | Why? |
| Endarterectomy, Carotid | 1 | 2019 | 78 | 0.76 | Why? |
| Coronary Vasospasm | 2 | 2019 | 36 | 0.76 | Why? |
| Cardiomyopathies | 2 | 2019 | 997 | 0.75 | Why? |
| Internal Mammary-Coronary Artery Anastomosis | 1 | 2018 | 11 | 0.75 | Why? |
| Peroxisome Proliferator-Activated Receptors | 1 | 2018 | 17 | 0.75 | Why? |
| Magnetic Resonance Angiography | 2 | 2018 | 282 | 0.75 | Why? |
| Incidence | 31 | 2020 | 25622 | 0.75 | Why? |
| Glaucoma, Open-Angle | 1 | 2019 | 55 | 0.74 | Why? |
| Embolism, Paradoxical | 1 | 2018 | 22 | 0.74 | Why? |
| Chlorthalidone | 1 | 2018 | 7 | 0.74 | Why? |
| Genetic Predisposition to Disease | 6 | 2018 | 4027 | 0.74 | Why? |
| Purinergic P2Y Receptor Antagonists | 2 | 2018 | 206 | 0.74 | Why? |
| Carotid Stenosis | 2 | 2019 | 207 | 0.74 | Why? |
| Tachycardia | 2 | 2017 | 239 | 0.74 | Why? |
| Prosthesis Failure | 2 | 2018 | 195 | 0.74 | Why? |
| Hypotension, Orthostatic | 1 | 2019 | 55 | 0.74 | Why? |
| Mammary Arteries | 1 | 2018 | 31 | 0.74 | Why? |
| No-Reflow Phenomenon | 1 | 2018 | 14 | 0.73 | Why? |
| Physical Endurance | 1 | 2019 | 107 | 0.73 | Why? |
| Renin | 1 | 2019 | 167 | 0.73 | Why? |
| Anti-Arrhythmia Agents | 2 | 2018 | 325 | 0.73 | Why? |
| Predictive Value of Tests | 13 | 2019 | 9537 | 0.73 | Why? |
| Anticoagulants | 7 | 2019 | 9563 | 0.73 | Why? |
| Ventricular Function, Right | 2 | 2019 | 388 | 0.73 | Why? |
| Anesthesia, Local | 2 | 2017 | 163 | 0.72 | Why? |
| Social Class | 2 | 2017 | 1360 | 0.72 | Why? |
| Heart Valve Diseases | 3 | 2017 | 355 | 0.72 | Why? |
| Food Quality | 1 | 2018 | 49 | 0.72 | Why? |
| Mitral Valve | 3 | 2019 | 342 | 0.72 | Why? |
| Vascular Resistance | 2 | 2017 | 148 | 0.72 | Why? |
| Nitric Oxide Donors | 1 | 2018 | 53 | 0.72 | Why? |
| Follow-Up Studies | 22 | 2019 | 17020 | 0.72 | Why? |
| Hyperlipidemia, Familial Combined | 1 | 2017 | 5 | 0.72 | Why? |
| Pulmonary Wedge Pressure | 1 | 2018 | 53 | 0.71 | Why? |
| Prilocaine | 1 | 2017 | 4 | 0.71 | Why? |
| Mitral Valve Annuloplasty | 1 | 2018 | 35 | 0.71 | Why? |
| Endarterectomy | 1 | 2018 | 60 | 0.71 | Why? |
| Receptors, Adrenergic, beta-2 | 1 | 2018 | 32 | 0.71 | Why? |
| Middle Aged | 87 | 2020 | 270681 | 0.71 | Why? |
| Blood Vessel Prosthesis | 1 | 2019 | 115 | 0.71 | Why? |
| Oxadiazoles | 1 | 2018 | 41 | 0.71 | Why? |
| Bacteria | 2 | 2019 | 1897 | 0.70 | Why? |
| Essential Hypertension | 1 | 2018 | 48 | 0.70 | Why? |
| Cardio-Renal Syndrome | 1 | 2019 | 68 | 0.70 | Why? |
| Temperament | 1 | 2018 | 58 | 0.70 | Why? |
| Antioxidants | 2 | 2019 | 1593 | 0.70 | Why? |
| Pericarditis, Constrictive | 1 | 2017 | 21 | 0.69 | Why? |
| Female | 99 | 2020 | 380317 | 0.69 | Why? |
| Cardiomyopathy, Dilated | 2 | 2017 | 251 | 0.69 | Why? |
| Endocardial Fibroelastosis | 1 | 2016 | 1 | 0.69 | Why? |
| Drug-Eluting Stents | 3 | 2019 | 562 | 0.69 | Why? |
| Angiogenesis Inducing Agents | 1 | 2017 | 11 | 0.69 | Why? |
| Melanins | 1 | 2017 | 42 | 0.69 | Why? |
| Lipocalin-2 | 1 | 2018 | 156 | 0.69 | Why? |
| Heart Aneurysm | 1 | 2018 | 46 | 0.69 | Why? |
| Gout Suppressants | 1 | 2018 | 54 | 0.69 | Why? |
| Inflammation Mediators | 4 | 2019 | 2654 | 0.69 | Why? |
| Vagus Nerve | 1 | 2017 | 57 | 0.68 | Why? |
| Heart Septal Defects, Atrial | 1 | 2018 | 61 | 0.68 | Why? |
| Neovascularization, Pathologic | 2 | 2018 | 305 | 0.68 | Why? |
| Endothelium | 2 | 2018 | 460 | 0.68 | Why? |
| Pain, Procedural | 1 | 2017 | 51 | 0.68 | Why? |
| Microcirculation | 3 | 2020 | 447 | 0.68 | Why? |
| Circulating MicroRNA | 1 | 2018 | 123 | 0.68 | Why? |
| Multidetector Computed Tomography | 2 | 2018 | 307 | 0.68 | Why? |
| Amiodarone | 1 | 2018 | 110 | 0.67 | Why? |
| Endothelial Progenitor Cells | 1 | 2018 | 103 | 0.67 | Why? |
| Endocannabinoids | 1 | 2017 | 56 | 0.66 | Why? |
| Lactobacillus rhamnosus | 1 | 2016 | 23 | 0.66 | Why? |
| Television | 1 | 2019 | 224 | 0.66 | Why? |
| Running | 1 | 2019 | 153 | 0.66 | Why? |
| Economics, Medical | 1 | 2017 | 35 | 0.66 | Why? |
| Mitral Valve Prolapse | 1 | 2016 | 24 | 0.66 | Why? |
| Hypoglycemic Agents | 4 | 2018 | 2165 | 0.65 | Why? |
| Sildenafil Citrate | 1 | 2017 | 66 | 0.64 | Why? |
| Adipokines | 1 | 2017 | 87 | 0.64 | Why? |
| Bioprosthesis | 1 | 2018 | 126 | 0.64 | Why? |
| Fractional Flow Reserve, Myocardial | 1 | 2018 | 173 | 0.64 | Why? |
| Genetic Therapy | 2 | 2018 | 409 | 0.63 | Why? |
| Functional Food | 1 | 2018 | 122 | 0.63 | Why? |
| Angina, Unstable | 1 | 2017 | 110 | 0.63 | Why? |
| Heart Arrest | 2 | 2017 | 1239 | 0.63 | Why? |
| Lidocaine | 1 | 2017 | 94 | 0.62 | Why? |
| Syncope | 1 | 2019 | 238 | 0.62 | Why? |
| Lipoproteins, LDL | 1 | 2017 | 115 | 0.62 | Why? |
| Natriuretic Peptide, Brain | 3 | 2018 | 1215 | 0.62 | Why? |
| Cardiac Imaging Techniques | 1 | 2019 | 357 | 0.62 | Why? |
| Bioengineering | 1 | 2016 | 72 | 0.62 | Why? |
| Echocardiography, Doppler | 1 | 2018 | 269 | 0.61 | Why? |
| Coronary Aneurysm | 1 | 2018 | 132 | 0.61 | Why? |
| Coronary Disease | 4 | 2020 | 645 | 0.61 | Why? |
| Cardiac Surgical Procedures | 2 | 2020 | 1931 | 0.61 | Why? |
| Diuretics | 1 | 2018 | 326 | 0.61 | Why? |
| Editorial Policies | 6 | 2019 | 408 | 0.60 | Why? |
| Heart Neoplasms | 1 | 2016 | 77 | 0.60 | Why? |
| Blood Vessel Prosthesis Implantation | 1 | 2019 | 226 | 0.60 | Why? |
| Tomography, Optical Coherence | 3 | 2018 | 1008 | 0.60 | Why? |
| Gastrointestinal Microbiome | 2 | 2019 | 1961 | 0.60 | Why? |
| Ticlopidine | 1 | 2017 | 193 | 0.60 | Why? |
| Prosthesis Implantation | 1 | 2018 | 261 | 0.59 | Why? |
| Doxorubicin | 1 | 2018 | 313 | 0.59 | Why? |
| Cardiology | 5 | 2019 | 2873 | 0.59 | Why? |
| Hemorrhage | 2 | 2019 | 3013 | 0.59 | Why? |
| Economics | 1 | 2017 | 196 | 0.59 | Why? |
| Bevacizumab | 1 | 2016 | 149 | 0.59 | Why? |
| Obesity | 6 | 2018 | 7388 | 0.59 | Why? |
| DNA Mutational Analysis | 1 | 2018 | 581 | 0.59 | Why? |
| Embolism | 1 | 2016 | 136 | 0.59 | Why? |
| Penicillins | 1 | 2016 | 132 | 0.58 | Why? |
| Blood Vessels | 1 | 2017 | 228 | 0.58 | Why? |
| Stem Cells | 3 | 2019 | 595 | 0.58 | Why? |
| Hyperlipoproteinemia Type II | 1 | 2017 | 123 | 0.58 | Why? |
| Polymorphism, Single Nucleotide | 3 | 2018 | 3607 | 0.58 | Why? |
| Lipoproteins, HDL | 1 | 2017 | 154 | 0.58 | Why? |
| Pericardium | 1 | 2017 | 228 | 0.57 | Why? |
| Hyponatremia | 1 | 2019 | 371 | 0.57 | Why? |
| Uric Acid | 1 | 2018 | 285 | 0.57 | Why? |
| Hospitals, General | 1 | 2020 | 711 | 0.57 | Why? |
| Stroke | 7 | 2019 | 8839 | 0.56 | Why? |
| Benzimidazoles | 1 | 2018 | 275 | 0.56 | Why? |
| Chest Pain | 1 | 2019 | 578 | 0.56 | Why? |
| Fibrosis | 4 | 2019 | 800 | 0.56 | Why? |
| Patient Admission | 3 | 2020 | 5250 | 0.56 | Why? |
| Drug Substitution | 1 | 2018 | 385 | 0.55 | Why? |
| Aorta, Thoracic | 1 | 2017 | 271 | 0.55 | Why? |
| Anesthetics, Local | 1 | 2017 | 205 | 0.55 | Why? |
| Nutrition Therapy | 1 | 2018 | 285 | 0.54 | Why? |
| Personality | 1 | 2018 | 277 | 0.54 | Why? |
| Water | 1 | 2019 | 765 | 0.54 | Why? |
| Sarcoidosis | 1 | 2018 | 271 | 0.54 | Why? |
| Pericardiocentesis | 3 | 2019 | 84 | 0.54 | Why? |
| Galectin 3 | 3 | 2019 | 76 | 0.53 | Why? |
| Angiotensinogen | 1 | 2013 | 7 | 0.53 | Why? |
| Cytochrome P-450 CYP11B2 | 1 | 2013 | 6 | 0.53 | Why? |
| beta-Thalassemia | 1 | 2017 | 200 | 0.53 | Why? |
| Heart Conduction System | 1 | 2017 | 266 | 0.53 | Why? |
| Blood Pressure Monitoring, Ambulatory | 1 | 2017 | 341 | 0.53 | Why? |
| Troponin | 5 | 2020 | 1058 | 0.53 | Why? |
| Bioethics | 2 | 2017 | 253 | 0.52 | Why? |
| Positron Emission Tomography Computed Tomography | 3 | 2018 | 1458 | 0.52 | Why? |
| Bioethical Issues | 1 | 2017 | 233 | 0.51 | Why? |
| Dipeptidyl-Peptidase IV Inhibitors | 1 | 2018 | 436 | 0.51 | Why? |
| Tobacco Smoking | 1 | 2017 | 349 | 0.51 | Why? |
| Neoplasm Metastasis | 1 | 2016 | 682 | 0.51 | Why? |
| Aneurysm, Dissecting | 1 | 2018 | 303 | 0.50 | Why? |
| Peritoneal Dialysis | 1 | 2019 | 498 | 0.50 | Why? |
| Muscle, Skeletal | 2 | 2017 | 915 | 0.50 | Why? |
| Glomerular Filtration Rate | 3 | 2018 | 1262 | 0.49 | Why? |
| Micronutrients | 1 | 2017 | 310 | 0.49 | Why? |
| Vascular Diseases | 3 | 2019 | 846 | 0.49 | Why? |
| Carotid Intima-Media Thickness | 3 | 2019 | 179 | 0.49 | Why? |
| Heart | 3 | 2020 | 1791 | 0.48 | Why? |
| Ventricular Dysfunction, Right | 2 | 2019 | 639 | 0.48 | Why? |
| Warfarin | 1 | 2017 | 402 | 0.48 | Why? |
| Takotsubo Cardiomyopathy | 1 | 2019 | 453 | 0.48 | Why? |
| C-Reactive Protein | 8 | 2020 | 7972 | 0.48 | Why? |
| Diabetic Retinopathy | 1 | 2017 | 347 | 0.48 | Why? |
| Cardiac Pacing, Artificial | 3 | 2019 | 160 | 0.47 | Why? |
| Antineoplastic Agents | 2 | 2019 | 3550 | 0.47 | Why? |
| Hyperlipidemias | 1 | 2015 | 290 | 0.47 | Why? |
| Vaping | 1 | 2019 | 436 | 0.47 | Why? |
| Cystatin C | 1 | 2013 | 125 | 0.47 | Why? |
| Interleukin-6 | 3 | 2020 | 7522 | 0.47 | Why? |
| Ischemia | 2 | 2018 | 901 | 0.47 | Why? |
| Prospective Studies | 27 | 2019 | 43301 | 0.46 | Why? |
| Adipose Tissue | 1 | 2017 | 612 | 0.46 | Why? |
| Coronary Thrombosis | 1 | 2016 | 433 | 0.45 | Why? |
| Disease Progression | 6 | 2020 | 13580 | 0.45 | Why? |
| Proportional Hazards Models | 7 | 2019 | 6543 | 0.45 | Why? |
| Prosthesis Design | 3 | 2019 | 594 | 0.45 | Why? |
| Tertiary Care Centers | 2 | 2020 | 8248 | 0.44 | Why? |
| Time Factors | 17 | 2020 | 31397 | 0.44 | Why? |
| Anti-Inflammatory Agents | 4 | 2021 | 6153 | 0.44 | Why? |
| Endocarditis | 1 | 2016 | 368 | 0.44 | Why? |
| Thromboembolism | 3 | 2019 | 2101 | 0.44 | Why? |
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2018 | 1454 | 0.44 | Why? |
| ST Elevation Myocardial Infarction | 2 | 2018 | 3051 | 0.44 | Why? |
| CD40 Ligand | 2 | 2010 | 121 | 0.44 | Why? |
| Pulmonary Artery | 1 | 2018 | 803 | 0.43 | Why? |
| Exercise Test | 2 | 2017 | 911 | 0.43 | Why? |
| Diabetes Mellitus | 5 | 2020 | 8207 | 0.43 | Why? |
| Overweight | 1 | 2017 | 916 | 0.43 | Why? |
| Recurrence | 8 | 2019 | 3675 | 0.42 | Why? |
| Hematopoietic Stem Cells | 1 | 2013 | 321 | 0.42 | Why? |
| Diabetes Complications | 2 | 2020 | 2358 | 0.41 | Why? |
| Cerebrovascular Disorders | 1 | 2018 | 1040 | 0.41 | Why? |
| Ultrasonography | 5 | 2020 | 4409 | 0.41 | Why? |
| Adiposity | 3 | 2017 | 329 | 0.41 | Why? |
| Life Style | 6 | 2018 | 2708 | 0.41 | Why? |
| Glycated Hemoglobin A | 1 | 2018 | 1316 | 0.41 | Why? |
| Nurse's Role | 1 | 2018 | 614 | 0.40 | Why? |
| Myocarditis | 3 | 2020 | 2731 | 0.39 | Why? |
| Oxidative Stress | 4 | 2019 | 2050 | 0.39 | Why? |
| Ergocalciferols | 2 | 2019 | 51 | 0.39 | Why? |
| Apoptosis | 2 | 2019 | 2335 | 0.38 | Why? |
| Smoking Cessation | 1 | 2017 | 826 | 0.38 | Why? |
| Breast Neoplasms | 2 | 2017 | 3633 | 0.38 | Why? |
| Diagnostic Imaging | 1 | 2017 | 1044 | 0.38 | Why? |
| Non-alcoholic Fatty Liver Disease | 1 | 2018 | 907 | 0.38 | Why? |
| Adult | 50 | 2020 | 244371 | 0.37 | Why? |
| Kaplan-Meier Estimate | 5 | 2020 | 4260 | 0.37 | Why? |
| Obesity, Metabolically Benign | 2 | 2019 | 20 | 0.37 | Why? |
| Chromosomes, Human, Pair 9 | 1 | 2008 | 196 | 0.37 | Why? |
| Immunomodulation | 1 | 2018 | 1472 | 0.37 | Why? |
| Hypertension, Pulmonary | 1 | 2018 | 970 | 0.37 | Why? |
| Medication Adherence | 1 | 2018 | 1270 | 0.36 | Why? |
| Prevalence | 12 | 2020 | 25773 | 0.36 | Why? |
| Compliance | 2 | 2018 | 28 | 0.36 | Why? |
| Receptors, Purinergic P2Y12 | 2 | 2018 | 42 | 0.36 | Why? |
| Cardiotonic Agents | 3 | 2019 | 418 | 0.36 | Why? |
| History, Ancient | 2 | 2019 | 141 | 0.35 | Why? |
| Drug Delivery Systems | 1 | 2018 | 1365 | 0.35 | Why? |
| Aged, 80 and over | 25 | 2020 | 88759 | 0.35 | Why? |
| Lipoprotein(a) | 2 | 2019 | 92 | 0.35 | Why? |
| Critical Pathways | 1 | 2018 | 1587 | 0.35 | Why? |
| Glycation End Products, Advanced | 2 | 2019 | 72 | 0.35 | Why? |
| Recovery of Function | 4 | 2019 | 2461 | 0.35 | Why? |
| Asymptomatic Diseases | 2 | 2018 | 3444 | 0.35 | Why? |
| Dietary Supplements | 2 | 2018 | 2251 | 0.34 | Why? |
| Tumor Necrosis Factor-alpha | 2 | 2017 | 2483 | 0.34 | Why? |
| Vitamins | 1 | 2017 | 1208 | 0.34 | Why? |
| Angiotensin Receptor Antagonists | 3 | 2020 | 3892 | 0.34 | Why? |
| Adrenal Cortex Hormones | 3 | 2021 | 6537 | 0.34 | Why? |
| Disease Management | 4 | 2019 | 6841 | 0.34 | Why? |
| Dilatation | 2 | 2019 | 181 | 0.33 | Why? |
| Oxidation-Reduction | 3 | 2019 | 540 | 0.33 | Why? |
| Brachial Artery | 2 | 2017 | 107 | 0.33 | Why? |
| Emergency Service, Hospital | 3 | 2020 | 14232 | 0.33 | Why? |
| Patient Care Management | 1 | 2018 | 1514 | 0.33 | Why? |
| Case-Control Studies | 10 | 2020 | 17671 | 0.32 | Why? |
| Risk Assessment | 15 | 2019 | 25439 | 0.32 | Why? |
| Renin-Angiotensin System | 2 | 2019 | 3661 | 0.32 | Why? |
| Serotonin Uptake Inhibitors | 1 | 2008 | 149 | 0.32 | Why? |
| Cardiac Electrophysiology | 2 | 2018 | 239 | 0.32 | Why? |
| Neoplasms | 4 | 2019 | 17251 | 0.31 | Why? |
| Parkinson Disease | 1 | 2019 | 1414 | 0.31 | Why? |
| Phenotype | 4 | 2018 | 4037 | 0.31 | Why? |
| Alleles | 4 | 2017 | 1557 | 0.31 | Why? |
| Single-Blind Method | 3 | 2019 | 1283 | 0.31 | Why? |
| Aging | 4 | 2019 | 3581 | 0.30 | Why? |
| Blood Flow Velocity | 2 | 2017 | 193 | 0.30 | Why? |
| Anesthesia | 1 | 2016 | 1236 | 0.30 | Why? |
| Clinical Decision-Making | 2 | 2017 | 3755 | 0.30 | Why? |
| Drug Resistance | 2 | 2019 | 395 | 0.30 | Why? |
| Gene Expression Regulation | 1 | 2019 | 4020 | 0.30 | Why? |
| Vasoconstriction | 2 | 2017 | 153 | 0.30 | Why? |
| Peptidyl-Dipeptidase A | 5 | 2020 | 9659 | 0.30 | Why? |
| Heptanoic Acids | 1 | 2005 | 13 | 0.30 | Why? |
| Cross-Over Studies | 3 | 2018 | 867 | 0.29 | Why? |
| Cardiac Tamponade | 2 | 2018 | 165 | 0.29 | Why? |
| Bradycardia | 3 | 2017 | 292 | 0.29 | Why? |
| Skin | 1 | 2017 | 2096 | 0.29 | Why? |
| Disease Models, Animal | 6 | 2019 | 10998 | 0.29 | Why? |
| Depression | 3 | 2020 | 14116 | 0.29 | Why? |
| Hyperemia | 1 | 2005 | 62 | 0.29 | Why? |
| Injections, Subcutaneous | 2 | 2017 | 647 | 0.28 | Why? |
| Reoperation | 2 | 2018 | 544 | 0.28 | Why? |
| Renal Insufficiency, Chronic | 1 | 2019 | 2654 | 0.28 | Why? |
| Secondary Prevention | 3 | 2019 | 762 | 0.28 | Why? |
| Postoperative Complications | 3 | 2019 | 5861 | 0.28 | Why? |
| Vitamin D Deficiency | 1 | 2018 | 1782 | 0.28 | Why? |
| Patient Acceptance of Health Care | 2 | 2020 | 5002 | 0.28 | Why? |
| Evidence-Based Medicine | 1 | 2018 | 3228 | 0.28 | Why? |
| Rabbits | 2 | 2018 | 1171 | 0.27 | Why? |
| Medicine, Chinese Traditional | 1 | 2017 | 2255 | 0.27 | Why? |
| Information Dissemination | 5 | 2017 | 2986 | 0.27 | Why? |
| Cardiopulmonary Resuscitation | 1 | 2017 | 1876 | 0.27 | Why? |
| Genotype | 5 | 2018 | 4697 | 0.27 | Why? |
| Intercellular Adhesion Molecule-1 | 2 | 2017 | 189 | 0.27 | Why? |
| Multivariate Analysis | 4 | 2019 | 5440 | 0.27 | Why? |
| Diabetes Mellitus, Type 1 | 1 | 2018 | 1969 | 0.27 | Why? |
| Consensus | 2 | 2019 | 6345 | 0.26 | Why? |
| Muscle, Smooth, Vascular | 2 | 2018 | 86 | 0.26 | Why? |
| Dyspnea | 1 | 2017 | 3847 | 0.26 | Why? |
| Urban Health | 2 | 2017 | 382 | 0.26 | Why? |
| Cause of Death | 6 | 2020 | 4823 | 0.26 | Why? |
| Arthritis, Rheumatoid | 1 | 2017 | 2043 | 0.26 | Why? |
| Cell- and Tissue-Based Therapy | 2 | 2018 | 422 | 0.26 | Why? |
| Antirheumatic Agents | 2 | 2020 | 3023 | 0.25 | Why? |
| Drug Combinations | 3 | 2018 | 3852 | 0.25 | Why? |
| Cognition | 5 | 2019 | 1394 | 0.25 | Why? |
| Blood Coagulation Disorders | 1 | 2017 | 2040 | 0.25 | Why? |
| Societies, Medical | 3 | 2017 | 6907 | 0.24 | Why? |
| Energy Metabolism | 2 | 2017 | 451 | 0.24 | Why? |
| Anticholesteremic Agents | 1 | 2005 | 186 | 0.24 | Why? |
| Colorectal Neoplasms | 1 | 2016 | 1884 | 0.24 | Why? |
| Forecasting | 1 | 2017 | 4492 | 0.24 | Why? |
| Regression Analysis | 3 | 2019 | 2484 | 0.24 | Why? |
| Magnetic Resonance Imaging | 1 | 2019 | 6551 | 0.24 | Why? |
| Models, Cardiovascular | 2 | 2018 | 153 | 0.23 | Why? |
| Dyslipidemias | 2 | 2020 | 791 | 0.23 | Why? |
| Pyrroles | 1 | 2005 | 292 | 0.23 | Why? |
| Myocytes, Cardiac | 2 | 2018 | 804 | 0.23 | Why? |
| Treatment Failure | 2 | 2018 | 2106 | 0.23 | Why? |
| Smoking | 4 | 2017 | 3358 | 0.23 | Why? |
| Periodicals as Topic | 4 | 2019 | 1492 | 0.23 | Why? |
| Acute Disease | 3 | 2019 | 6029 | 0.22 | Why? |
| Albuminuria | 2 | 2017 | 164 | 0.22 | Why? |
| Brain Ischemia | 1 | 2017 | 2813 | 0.22 | Why? |
| Punctures | 2 | 2018 | 89 | 0.22 | Why? |
| Vascular Cell Adhesion Molecule-1 | 3 | 2013 | 121 | 0.22 | Why? |
| Probiotics | 2 | 2019 | 694 | 0.22 | Why? |
| Morbidity | 2 | 2017 | 1426 | 0.22 | Why? |
| Survival Rate | 4 | 2018 | 9206 | 0.22 | Why? |
| Sex Factors | 7 | 2019 | 11014 | 0.22 | Why? |
| Nitric Oxide | 2 | 2018 | 769 | 0.21 | Why? |
| Health Status | 3 | 2019 | 3259 | 0.21 | Why? |
| Comorbidity | 7 | 2020 | 34796 | 0.21 | Why? |
| Social Isolation | 1 | 2020 | 5932 | 0.20 | Why? |
| Administration, Oral | 2 | 2018 | 2340 | 0.20 | Why? |
| Survival | 1 | 2019 | 53 | 0.20 | Why? |
| Troponin C | 1 | 2019 | 29 | 0.20 | Why? |
| Interleukin-1 Receptor-Like 1 Protein | 1 | 2020 | 92 | 0.20 | Why? |
| Sutureless Surgical Procedures | 1 | 2019 | 6 | 0.20 | Why? |
| Pulse | 2 | 2017 | 37 | 0.20 | Why? |
| Plethysmography | 2 | 2017 | 30 | 0.20 | Why? |
| Waist Circumference | 2 | 2017 | 199 | 0.20 | Why? |
| Arginine | 2 | 2017 | 377 | 0.20 | Why? |
| Surgical Stapling | 1 | 2019 | 19 | 0.20 | Why? |
| Adenosine Triphosphatases | 1 | 2019 | 78 | 0.19 | Why? |
| Ischemic Preconditioning, Myocardial | 1 | 2018 | 18 | 0.19 | Why? |
| Sodium, Dietary | 1 | 2019 | 45 | 0.19 | Why? |
| Dietary Carbohydrates | 1 | 2019 | 64 | 0.19 | Why? |
| Cognitive Dysfunction | 4 | 2019 | 1389 | 0.19 | Why? |
| Hematopoietic Stem Cell Transplantation | 1 | 2013 | 2426 | 0.19 | Why? |
| Chronic Disease | 3 | 2018 | 5139 | 0.19 | Why? |
| Pericardiectomy | 1 | 2018 | 21 | 0.19 | Why? |
| Tubulin Modulators | 1 | 2020 | 126 | 0.19 | Why? |
| Adrenergic beta-1 Receptor Antagonists | 1 | 2018 | 47 | 0.19 | Why? |
| Metoprolol | 1 | 2018 | 42 | 0.19 | Why? |
| Hippocratic Oath | 1 | 2018 | 34 | 0.19 | Why? |
| Consumer Product Safety | 1 | 2019 | 57 | 0.19 | Why? |
| Authorship | 2 | 2019 | 240 | 0.19 | Why? |
| Depressive Disorder, Major | 1 | 2008 | 852 | 0.19 | Why? |
| NADPH Oxidases | 1 | 2019 | 80 | 0.19 | Why? |
| Retrospective Studies | 11 | 2020 | 105322 | 0.18 | Why? |
| Vascular Surgical Procedures | 2 | 2018 | 882 | 0.18 | Why? |
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2017 | 16 | 0.18 | Why? |
| Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels | 1 | 2017 | 19 | 0.18 | Why? |
| Superoxide Dismutase | 1 | 2019 | 155 | 0.18 | Why? |
| Growth Differentiation Factor 15 | 1 | 2019 | 89 | 0.18 | Why? |
| Ankle Brachial Index | 1 | 2018 | 53 | 0.18 | Why? |
| Heredity | 1 | 2018 | 37 | 0.18 | Why? |
| Severity of Illness Index | 11 | 2020 | 48226 | 0.18 | Why? |
| Ventricular Fibrillation | 1 | 2019 | 126 | 0.18 | Why? |
| Cardiac Resynchronization Therapy Devices | 1 | 2018 | 64 | 0.18 | Why? |
| Olea | 1 | 2018 | 20 | 0.18 | Why? |
| Ulnar Artery | 1 | 2017 | 11 | 0.18 | Why? |
| Aldosterone | 1 | 2019 | 155 | 0.18 | Why? |
| Homocysteine | 1 | 2018 | 83 | 0.18 | Why? |
| Atrial Natriuretic Factor | 1 | 2018 | 75 | 0.18 | Why? |
| Anastomosis, Surgical | 1 | 2019 | 169 | 0.18 | Why? |
| Aortitis | 1 | 2018 | 39 | 0.18 | Why? |
| Reproducibility of Results | 4 | 2018 | 11304 | 0.18 | Why? |
| Angiography, Digital Subtraction | 1 | 2018 | 123 | 0.18 | Why? |
| Peroneal Nerve | 1 | 2017 | 13 | 0.18 | Why? |
| Anthracyclines | 1 | 2017 | 65 | 0.18 | Why? |
| Autonomic Pathways | 1 | 2017 | 8 | 0.18 | Why? |
| Scavenger Receptors, Class E | 1 | 2018 | 50 | 0.18 | Why? |
| Ascites | 1 | 2018 | 65 | 0.18 | Why? |
| Adiponectin | 2 | 2017 | 123 | 0.18 | Why? |
| Microelectrodes | 1 | 2017 | 15 | 0.18 | Why? |
| Endothelial Cells | 2 | 2019 | 2048 | 0.18 | Why? |
| Galectins | 1 | 2018 | 109 | 0.18 | Why? |
| Neuropeptide Y | 1 | 2017 | 14 | 0.17 | Why? |
| Cytochrome P-450 CYP2C19 | 1 | 2017 | 25 | 0.17 | Why? |
| Gene Frequency | 3 | 2018 | 1210 | 0.17 | Why? |
| Pressoreceptors | 1 | 2017 | 11 | 0.17 | Why? |
| Sinus of Valsalva | 1 | 2017 | 12 | 0.17 | Why? |
| Mice, Knockout, ApoE | 1 | 2017 | 42 | 0.17 | Why? |
| Microvascular Angina | 1 | 2017 | 19 | 0.17 | Why? |
| Prediabetic State | 2 | 2017 | 200 | 0.17 | Why? |
| Prasugrel Hydrochloride | 1 | 2018 | 114 | 0.17 | Why? |
| Hindlimb | 1 | 2017 | 21 | 0.17 | Why? |
| Ointments | 1 | 2017 | 54 | 0.17 | Why? |
| Ultrasonography, Doppler, Color | 1 | 2018 | 107 | 0.17 | Why? |
| Personality Disorders | 1 | 2018 | 81 | 0.17 | Why? |
| Cardiovascular Abnormalities | 1 | 2018 | 72 | 0.17 | Why? |
| Subcutaneous Tissue | 1 | 2017 | 18 | 0.17 | Why? |
| Literacy | 1 | 2017 | 53 | 0.17 | Why? |
| Glucagon-Like Peptide-1 Receptor | 1 | 2018 | 138 | 0.17 | Why? |
| E-Selectin | 1 | 2017 | 55 | 0.17 | Why? |
| Thrombosis | 3 | 2017 | 7504 | 0.17 | Why? |
| Non-Randomized Controlled Trials as Topic | 1 | 2018 | 220 | 0.17 | Why? |
| Mutation | 1 | 2018 | 12376 | 0.17 | Why? |
| Cholesterol, LDL | 2 | 2020 | 499 | 0.17 | Why? |
| Randomized Controlled Trials as Topic | 5 | 2020 | 10649 | 0.17 | Why? |
| Entropy | 1 | 2016 | 52 | 0.17 | Why? |
| Spinal Cord Stimulation | 1 | 2017 | 25 | 0.17 | Why? |
| Collagen | 1 | 2019 | 222 | 0.17 | Why? |
| Body Mass Index | 4 | 2017 | 4306 | 0.17 | Why? |
| Thermography | 1 | 2018 | 97 | 0.17 | Why? |
| Myocytes, Smooth Muscle | 1 | 2018 | 127 | 0.16 | Why? |
| Homozygote | 1 | 2018 | 230 | 0.16 | Why? |
| Clinical Trials Data Monitoring Committees | 1 | 2017 | 58 | 0.16 | Why? |
| Publishing | 2 | 2017 | 990 | 0.16 | Why? |
| Alcohol Drinking | 2 | 2019 | 1663 | 0.16 | Why? |
| Extremities | 1 | 2018 | 179 | 0.16 | Why? |
| Ultrasonography, Doppler, Duplex | 1 | 2018 | 168 | 0.16 | Why? |
| Radiography | 2 | 2015 | 1576 | 0.16 | Why? |
| Patient Compliance | 2 | 2017 | 1468 | 0.16 | Why? |
| Biological Variation, Population | 1 | 2017 | 69 | 0.16 | Why? |
| Pedigree | 1 | 2018 | 502 | 0.16 | Why? |
| Bundle-Branch Block | 1 | 2017 | 127 | 0.16 | Why? |
| Age Factors | 8 | 2019 | 21039 | 0.16 | Why? |
| Journalism, Medical | 1 | 2017 | 50 | 0.16 | Why? |
| Administration, Cutaneous | 1 | 2017 | 229 | 0.16 | Why? |
| Genetic Markers | 1 | 2018 | 318 | 0.16 | Why? |
| Intraocular Pressure | 1 | 2019 | 276 | 0.16 | Why? |
| Practice Guidelines as Topic | 5 | 2019 | 15421 | 0.16 | Why? |
| Network Meta-Analysis | 1 | 2018 | 426 | 0.16 | Why? |
| Cyclopropanes | 1 | 2018 | 332 | 0.16 | Why? |
| Glucose Tolerance Test | 1 | 2017 | 238 | 0.16 | Why? |
| Insulin Infusion Systems | 1 | 2018 | 256 | 0.16 | Why? |
| Postoperative Period | 1 | 2018 | 651 | 0.16 | Why? |
| Healthy Aging | 1 | 2018 | 147 | 0.15 | Why? |
| Equipment Design | 2 | 2017 | 3095 | 0.15 | Why? |
| Vagus Nerve Stimulation | 1 | 2017 | 77 | 0.15 | Why? |
| Age of Onset | 1 | 2018 | 557 | 0.15 | Why? |
| Plasminogen Activator Inhibitor 1 | 1 | 2017 | 162 | 0.15 | Why? |
| Fibrinolytic Agents | 2 | 2018 | 1702 | 0.15 | Why? |
| Nucleotides | 1 | 2018 | 212 | 0.15 | Why? |
| Etanercept | 1 | 2017 | 162 | 0.15 | Why? |
| Optical Imaging | 1 | 2017 | 197 | 0.15 | Why? |
| Calibration | 1 | 2017 | 307 | 0.15 | Why? |
| Adolescent | 11 | 2019 | 86841 | 0.15 | Why? |
| Aneurysm | 1 | 2017 | 117 | 0.15 | Why? |
| Platelet Function Tests | 1 | 2017 | 231 | 0.15 | Why? |
| Everolimus | 1 | 2018 | 215 | 0.15 | Why? |
| Organ Size | 1 | 2017 | 384 | 0.15 | Why? |
| Nonlinear Dynamics | 1 | 2016 | 177 | 0.15 | Why? |
| Radiopharmaceuticals | 2 | 2018 | 763 | 0.15 | Why? |
| Fruit | 1 | 2018 | 313 | 0.15 | Why? |
| Obesity, Abdominal | 1 | 2017 | 167 | 0.15 | Why? |
| Angiography | 1 | 2017 | 301 | 0.15 | Why? |
| Brugada Syndrome | 1 | 2017 | 98 | 0.15 | Why? |
| Pulmonary Veins | 1 | 2017 | 146 | 0.15 | Why? |
| Valsartan | 1 | 2017 | 206 | 0.15 | Why? |
| Biphenyl Compounds | 1 | 2017 | 249 | 0.15 | Why? |
| Aminobutyrates | 1 | 2017 | 142 | 0.15 | Why? |
| Monitoring, Ambulatory | 1 | 2019 | 343 | 0.15 | Why? |
| Iatrogenic Disease | 1 | 2018 | 304 | 0.15 | Why? |
| Absorbable Implants | 1 | 2018 | 191 | 0.15 | Why? |
| Cross-Sectional Studies | 7 | 2019 | 53120 | 0.14 | Why? |
| Principal Component Analysis | 1 | 2017 | 689 | 0.14 | Why? |
| Chemokines | 1 | 2021 | 1095 | 0.14 | Why? |
| Vascular Endothelial Growth Factor A | 1 | 2019 | 604 | 0.14 | Why? |
| Blood Proteins | 1 | 2018 | 551 | 0.14 | Why? |
| Return to Sport | 1 | 2020 | 456 | 0.14 | Why? |
| Platelet Aggregation | 1 | 2017 | 318 | 0.14 | Why? |
| Statistics as Topic | 1 | 2017 | 370 | 0.14 | Why? |
| Intra-Abdominal Fat | 1 | 2017 | 227 | 0.14 | Why? |
| Myocardial Revascularization | 1 | 2017 | 267 | 0.14 | Why? |
| Myelodysplastic Syndromes | 1 | 2017 | 261 | 0.14 | Why? |
| Cohort Studies | 7 | 2019 | 36005 | 0.14 | Why? |
| Blood Coagulation | 2 | 2019 | 2768 | 0.14 | Why? |
| Electric Countershock | 1 | 2017 | 284 | 0.14 | Why? |
| Edema | 1 | 2018 | 333 | 0.14 | Why? |
| Infusions, Intralesional | 1 | 2013 | 3 | 0.14 | Why? |
| Genetic Association Studies | 1 | 2018 | 559 | 0.14 | Why? |
| Protein Precursors | 1 | 2018 | 425 | 0.14 | Why? |
| Global Health | 4 | 2018 | 13911 | 0.14 | Why? |
| Healthy Volunteers | 2 | 2018 | 1444 | 0.14 | Why? |
| Mortality | 3 | 2020 | 7132 | 0.14 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 3 | 2020 | 5277 | 0.13 | Why? |
| Tetrazoles | 1 | 2017 | 262 | 0.13 | Why? |
| Oncology Service, Hospital | 1 | 2017 | 314 | 0.13 | Why? |
| Hypercholesterolemia | 1 | 2016 | 175 | 0.13 | Why? |
| Pain Measurement | 1 | 2017 | 533 | 0.13 | Why? |
| Drug Administration Schedule | 2 | 2019 | 2324 | 0.13 | Why? |
| Chi-Square Distribution | 1 | 2017 | 961 | 0.13 | Why? |
| Death | 1 | 2017 | 334 | 0.13 | Why? |
| Incidental Findings | 1 | 2018 | 487 | 0.13 | Why? |
| Ventricular Remodeling | 1 | 2017 | 349 | 0.13 | Why? |
| Quality of Life | 3 | 2019 | 9820 | 0.13 | Why? |
| Early Medical Intervention | 1 | 2017 | 487 | 0.13 | Why? |
| Exercise | 3 | 2019 | 6771 | 0.13 | Why? |
| Europe | 3 | 2020 | 12702 | 0.13 | Why? |
| Lipid Metabolism | 1 | 2018 | 572 | 0.13 | Why? |
| Cardiorespiratory Fitness | 1 | 2017 | 313 | 0.13 | Why? |
| Fluorodeoxyglucose F18 | 2 | 2018 | 1153 | 0.13 | Why? |
| Dementia | 2 | 2017 | 1861 | 0.13 | Why? |
| Health Status Indicators | 1 | 2016 | 341 | 0.13 | Why? |
| Clinical Trials as Topic | 3 | 2017 | 7330 | 0.13 | Why? |
| Adalimumab | 1 | 2017 | 389 | 0.13 | Why? |
| Women's Health | 1 | 2018 | 444 | 0.12 | Why? |
| Allied Health Personnel | 1 | 2017 | 416 | 0.12 | Why? |
| Cell Count | 1 | 2013 | 228 | 0.12 | Why? |
| Angiotensin II Type 1 Receptor Blockers | 1 | 2018 | 520 | 0.12 | Why? |
| Blood Glucose Self-Monitoring | 1 | 2018 | 791 | 0.12 | Why? |
| Infliximab | 1 | 2017 | 502 | 0.12 | Why? |
| Dysbiosis | 1 | 2019 | 685 | 0.12 | Why? |
| Angiogenesis Inhibitors | 1 | 2016 | 395 | 0.12 | Why? |
| Administration, Intravenous | 1 | 2016 | 1115 | 0.12 | Why? |
| Oximetry | 1 | 2017 | 658 | 0.12 | Why? |
| Pyridines | 1 | 2018 | 680 | 0.12 | Why? |
| Syndrome | 1 | 2018 | 1310 | 0.12 | Why? |
| Arterial Occlusive Diseases | 1 | 2017 | 363 | 0.12 | Why? |
| Body Weight | 1 | 2018 | 1074 | 0.12 | Why? |
| Cardiovascular Agents | 1 | 2018 | 663 | 0.12 | Why? |
| Pre-Eclampsia | 1 | 2019 | 599 | 0.12 | Why? |
| Image Interpretation, Computer-Assisted | 1 | 2019 | 665 | 0.12 | Why? |
| Contrast Media | 1 | 2018 | 1011 | 0.12 | Why? |
| Chemoprevention | 1 | 2016 | 585 | 0.12 | Why? |
| Nutrition Surveys | 3 | 2018 | 287 | 0.12 | Why? |
| Lower Extremity | 1 | 2017 | 593 | 0.11 | Why? |
| Risk Reduction Behavior | 1 | 2019 | 946 | 0.11 | Why? |
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2011 | 36 | 0.11 | Why? |
| Anesthesia, General | 1 | 2016 | 470 | 0.11 | Why? |
| Cognition Disorders | 1 | 2017 | 574 | 0.11 | Why? |
| Circadian Rhythm | 1 | 2017 | 607 | 0.11 | Why? |
| Economic Recession | 1 | 2017 | 453 | 0.11 | Why? |
| Hemoglobins | 1 | 2017 | 958 | 0.11 | Why? |
| Observational Studies as Topic | 1 | 2019 | 1887 | 0.11 | Why? |
| Young Adult | 10 | 2019 | 93724 | 0.11 | Why? |
| Child | 5 | 2018 | 70012 | 0.11 | Why? |
| Preventive Health Services | 1 | 2017 | 501 | 0.11 | Why? |
| Metabolic Diseases | 1 | 2017 | 505 | 0.11 | Why? |
| Calcium Channel Blockers | 1 | 2014 | 367 | 0.11 | Why? |
| Virus Internalization | 2 | 2020 | 7921 | 0.11 | Why? |
| Protective Factors | 1 | 2017 | 1720 | 0.11 | Why? |
| Interleukin 1 Receptor Antagonist Protein | 1 | 2019 | 1165 | 0.11 | Why? |
| Ribavirin | 1 | 2018 | 1182 | 0.11 | Why? |
| Sweden | 1 | 2018 | 1969 | 0.11 | Why? |
| Computed Tomography Angiography | 2 | 2018 | 2153 | 0.11 | Why? |
| Feeding Behavior | 3 | 2018 | 1909 | 0.10 | Why? |
| Up-Regulation | 1 | 2018 | 2249 | 0.10 | Why? |
| Datasets as Topic | 1 | 2017 | 1404 | 0.10 | Why? |
| Israel | 1 | 2019 | 2751 | 0.10 | Why? |
| Immunohistochemistry | 2 | 2017 | 2275 | 0.10 | Why? |
| Cytokines | 3 | 2021 | 15010 | 0.10 | Why? |
| Interdisciplinary Communication | 1 | 2017 | 1425 | 0.10 | Why? |
| Insulin | 1 | 2018 | 1316 | 0.10 | Why? |
| Guidelines as Topic | 3 | 2017 | 2844 | 0.10 | Why? |
| Hospitalization | 6 | 2020 | 54280 | 0.10 | Why? |
| Child, Preschool | 3 | 2018 | 36283 | 0.10 | Why? |
| Antineoplastic Agents, Immunological | 1 | 2016 | 830 | 0.10 | Why? |
| Forearm | 2 | 2008 | 52 | 0.09 | Why? |
| Diastole | 2 | 2019 | 168 | 0.09 | Why? |
| Hepatitis C, Chronic | 1 | 2018 | 973 | 0.09 | Why? |
| Protein Kinase Inhibitors | 1 | 2018 | 1585 | 0.09 | Why? |
| Host-Pathogen Interactions | 2 | 2019 | 11041 | 0.09 | Why? |
| Diet | 2 | 2017 | 2052 | 0.09 | Why? |
| Heart Defects, Congenital | 1 | 2017 | 933 | 0.09 | Why? |
| Tomography, X-Ray Computed | 4 | 2018 | 25144 | 0.08 | Why? |
| Pandemics | 7 | 2020 | 389249 | 0.08 | Why? |
| Pneumonia, Viral | 6 | 2020 | 243684 | 0.08 | Why? |
| Alzheimer Disease | 1 | 2017 | 1020 | 0.08 | Why? |
| Ramipril | 1 | 2008 | 81 | 0.08 | Why? |
| Coronavirus Infections | 6 | 2020 | 253789 | 0.08 | Why? |
| Blood Glucose | 2 | 2018 | 3642 | 0.08 | Why? |
| Pregnancy | 3 | 2019 | 23879 | 0.08 | Why? |
| Risk | 2 | 2018 | 5288 | 0.08 | Why? |
| Coronary Circulation | 2 | 2020 | 188 | 0.08 | Why? |
| Survival Analysis | 2 | 2018 | 7592 | 0.08 | Why? |
| Double-Blind Method | 1 | 2018 | 5988 | 0.08 | Why? |
| Self Report | 1 | 2019 | 3802 | 0.08 | Why? |
| Plant Extracts | 1 | 2018 | 1514 | 0.08 | Why? |
| Autopsy | 1 | 2018 | 3495 | 0.08 | Why? |
| Health Services Accessibility | 2 | 2020 | 10697 | 0.08 | Why? |
| Outpatients | 1 | 2019 | 3417 | 0.08 | Why? |
| Vasodilator Agents | 2 | 2006 | 344 | 0.08 | Why? |
| Mucocutaneous Lymph Node Syndrome | 1 | 2018 | 1645 | 0.08 | Why? |
| Pyridazines | 1 | 2006 | 86 | 0.08 | Why? |
| Early Detection of Cancer | 1 | 2017 | 1956 | 0.08 | Why? |
| Interferons | 1 | 2018 | 2885 | 0.07 | Why? |
| Time | 1 | 2008 | 631 | 0.07 | Why? |
| Hydrazones | 1 | 2006 | 216 | 0.07 | Why? |
| Odds Ratio | 1 | 2017 | 5861 | 0.07 | Why? |
| Health Services Needs and Demand | 1 | 2020 | 3419 | 0.07 | Why? |
| Infant | 2 | 2018 | 30274 | 0.07 | Why? |
| Pilot Projects | 1 | 2017 | 5182 | 0.07 | Why? |
| Guideline Adherence | 1 | 2017 | 2309 | 0.07 | Why? |
| Community-Acquired Infections | 1 | 2016 | 2328 | 0.07 | Why? |
| Fibrin Fibrinogen Degradation Products | 1 | 2020 | 5993 | 0.07 | Why? |
| Oxygen | 1 | 2017 | 3715 | 0.07 | Why? |
| Liver | 1 | 2018 | 4007 | 0.07 | Why? |
| Vitamin D | 1 | 2019 | 2904 | 0.07 | Why? |
| Databases, Factual | 1 | 2019 | 6248 | 0.06 | Why? |
| Intercellular Signaling Peptides and Proteins | 1 | 2005 | 245 | 0.06 | Why? |
| Immunologic Factors | 1 | 2019 | 4206 | 0.06 | Why? |
| Patient Care Team | 1 | 2017 | 3556 | 0.06 | Why? |
| Betacoronavirus | 5 | 2020 | 204454 | 0.06 | Why? |
| Registries | 2 | 2019 | 12327 | 0.06 | Why? |
| Mice, Inbred C57BL | 1 | 2013 | 5542 | 0.06 | Why? |
| Signal Transduction | 2 | 2017 | 7207 | 0.06 | Why? |
| Surveys and Questionnaires | 3 | 2019 | 43792 | 0.06 | Why? |
| Emergencies | 1 | 2017 | 4095 | 0.06 | Why? |
| Cells, Cultured | 1 | 2013 | 5835 | 0.06 | Why? |
| Neuropsychological Tests | 2 | 2017 | 954 | 0.06 | Why? |
| Troponin I | 2 | 2020 | 1298 | 0.06 | Why? |
| Patient Discharge | 1 | 2018 | 5696 | 0.06 | Why? |
| Medical Oncology | 1 | 2017 | 3826 | 0.05 | Why? |
| Drug Interactions | 1 | 2008 | 1653 | 0.05 | Why? |
| Mass Screening | 2 | 2017 | 8005 | 0.05 | Why? |
| Ventricular Pressure | 1 | 2019 | 25 | 0.05 | Why? |
| Biomedical Research | 2 | 2017 | 5270 | 0.05 | Why? |
| Sensitivity and Specificity | 2 | 2017 | 22971 | 0.05 | Why? |
| Beer | 1 | 2018 | 14 | 0.05 | Why? |
| Socioeconomic Factors | 1 | 2017 | 8495 | 0.05 | Why? |
| Glucagon-Like Peptides | 1 | 2018 | 29 | 0.05 | Why? |
| Liraglutide | 1 | 2018 | 47 | 0.05 | Why? |
| Heart Function Tests | 1 | 2019 | 101 | 0.05 | Why? |
| Proprotein Convertase 9 | 1 | 2020 | 141 | 0.05 | Why? |
| Glucagon-Like Peptide 1 | 1 | 2018 | 83 | 0.05 | Why? |
| Pulmonary Embolism | 1 | 2018 | 4775 | 0.05 | Why? |
| Waist-Height Ratio | 1 | 2017 | 13 | 0.04 | Why? |
| Vena Cava, Superior | 1 | 2017 | 30 | 0.04 | Why? |
| Wine | 1 | 2018 | 57 | 0.04 | Why? |
| United States | 3 | 2020 | 46150 | 0.04 | Why? |
| Adipose Tissue, Brown | 1 | 2017 | 20 | 0.04 | Why? |
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2017 | 46 | 0.04 | Why? |
| Waist-Hip Ratio | 1 | 2017 | 50 | 0.04 | Why? |
| Adipose Tissue, White | 1 | 2017 | 30 | 0.04 | Why? |
| Vasomotor System | 1 | 2017 | 13 | 0.04 | Why? |
| Vascular Patency | 1 | 2017 | 96 | 0.04 | Why? |
| Health Knowledge, Attitudes, Practice | 1 | 2020 | 8811 | 0.04 | Why? |
| Infant, Newborn | 1 | 2018 | 23105 | 0.04 | Why? |
| Antigens, Differentiation, Myelomonocytic | 1 | 2017 | 198 | 0.04 | Why? |
| Trophoblasts | 1 | 2019 | 237 | 0.04 | Why? |
| Autonomic Nervous System Diseases | 1 | 2017 | 67 | 0.04 | Why? |
| Mental Status and Dementia Tests | 1 | 2017 | 208 | 0.04 | Why? |
| Anthropometry | 1 | 2017 | 233 | 0.04 | Why? |
| Factor Analysis, Statistical | 1 | 2017 | 538 | 0.04 | Why? |
| Algorithms | 3 | 2020 | 7346 | 0.03 | Why? |
| Reference Values | 1 | 2017 | 795 | 0.03 | Why? |
| Ultrasonography, Doppler | 1 | 2018 | 406 | 0.03 | Why? |
| Social Responsibility | 1 | 2019 | 363 | 0.03 | Why? |
| Cellular Senescence | 1 | 2017 | 326 | 0.03 | Why? |
| Immunoglobulin G | 1 | 2018 | 21571 | 0.03 | Why? |
| Mice | 1 | 2013 | 21357 | 0.03 | Why? |
| International Cooperation | 2 | 2017 | 3436 | 0.03 | Why? |
| Quarantine | 1 | 2020 | 18418 | 0.03 | Why? |
| Weight Loss | 1 | 2018 | 826 | 0.03 | Why? |
| Infusions, Intravenous | 1 | 2017 | 1224 | 0.03 | Why? |
| Longitudinal Studies | 2 | 2019 | 9893 | 0.03 | Why? |
| Healthy Lifestyle | 1 | 2017 | 447 | 0.03 | Why? |
| Antigens, CD | 1 | 2017 | 984 | 0.03 | Why? |
| Disclosure | 1 | 2017 | 423 | 0.03 | Why? |
| Athletes | 1 | 2020 | 1047 | 0.03 | Why? |
| Imaging, Three-Dimensional | 1 | 2017 | 680 | 0.03 | Why? |
| Meta-Analysis as Topic | 1 | 2018 | 1289 | 0.03 | Why? |
| United States Food and Drug Administration | 1 | 2018 | 1276 | 0.03 | Why? |
| Heterozygote | 1 | 2011 | 249 | 0.03 | Why? |
| Logistic Models | 2 | 2018 | 9089 | 0.03 | Why? |
| Patient Readmission | 1 | 2019 | 1543 | 0.02 | Why? |
| Valine | 1 | 2011 | 359 | 0.02 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2005 | 7868 | 0.02 | Why? |
| Hepacivirus | 1 | 2018 | 1509 | 0.02 | Why? |
| Diarrhea | 1 | 2020 | 2743 | 0.02 | Why? |
| Telephone | 1 | 2017 | 1705 | 0.02 | Why? |
| Health Care Surveys | 1 | 2018 | 2942 | 0.02 | Why? |
| Heart Transplantation | 1 | 2017 | 1293 | 0.02 | Why? |
| Monitoring, Physiologic | 1 | 2018 | 1956 | 0.02 | Why? |
| Health Surveys | 1 | 2017 | 2841 | 0.02 | Why? |
| Symptom Assessment | 1 | 2020 | 4967 | 0.02 | Why? |
| Fibrinogen | 1 | 2011 | 1048 | 0.02 | Why? |
| Injections, Intra-Arterial | 1 | 2004 | 12 | 0.02 | Why? |
| Nitric Oxide Synthase | 1 | 2004 | 37 | 0.02 | Why? |
| Antiviral Agents | 1 | 2018 | 41703 | 0.02 | Why? |
| Stereoisomerism | 1 | 2004 | 121 | 0.02 | Why? |
| Acetylcholine | 1 | 2004 | 53 | 0.02 | Why? |
| Internationality | 1 | 2017 | 3297 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2018 | 7268 | 0.02 | Why? |
| Australia | 1 | 2017 | 6306 | 0.02 | Why? |
| Angina Pectoris | 1 | 2004 | 114 | 0.02 | Why? |
| Biological Transport | 1 | 2004 | 290 | 0.02 | Why? |
| Interleukin-1beta | 1 | 2008 | 992 | 0.02 | Why? |
| Patient Safety | 1 | 2017 | 4885 | 0.01 | Why? |
| Research Design | 1 | 2017 | 5830 | 0.01 | Why? |
| Atropine | 1 | 1997 | 18 | 0.01 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 9335 | 0.01 | Why? |
| Respiration, Artificial | 1 | 2020 | 22116 | 0.01 | Why? |
| Italy | 1 | 2018 | 38444 | 0.01 | Why? |
| Alanine | 1 | 2011 | 5687 | 0.01 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |